Cargando…

Real-World Evidence from the Integrative Medicine Primary Care Trial (IMPACT): Assessing Patient-Reported Outcomes at Baseline and 12-Month Follow-Up

PURPOSE: The University of Arizona Integrative Health Center (UAIHC) was an innovative membership-supported integrative medicine (IM) adult primary care clinic in Phoenix, Arizona. UAIHC delivered healthcare using an integrative medicine model that combined conventional and complementary medical tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crocker, Robert L., Hurwitz, Jason T., Grizzle, Amy J., Abraham, Ivo, Rehfeld, Rick, Horwitz, Randy, Weil, Andrew T., Maizes, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617880/ https://www.ncbi.nlm.nih.gov/pubmed/31346339 http://dx.doi.org/10.1155/2019/8595409

Ejemplares similares

Integrative medicine primary care: assessing the practice model through patients’ experiences
por: Crocker, Robert L., et al.
Publicado: (2017)

IMPACT - Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model
por: Herman, Patricia M, et al.
Publicado: (2014)

When a Whole Practice Model Is the Intervention: Developing Fidelity Evaluation Components Using Program Theory-Driven Science for an Integrative Medicine Primary Care Clinic
por: Dodds, Sally E., et al.
Publicado: (2013)

Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care
por: Hurwitz, Jason T., et al.
Publicado: (2016)

Integrative considerations during the COVID-19 pandemic
por: Alschuler, Lise, et al.
Publicado: (2020)

Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease
por: Alschuler, Lise, et al.
Publicado: (2022)

29C. The University of Arizona Integrative Health Center: The Development and Testing of a New Business Model for Integrative Primary Care
por: Herman, Patricia, et al.
Publicado: (2013)

Real-world effectiveness of smoking cessation aids: A population survey in England with 12-month follow-up, 2015–2020
por: Jackson, Sarah E., et al.
Publicado: (2022)

Cerebral Aneurysm Occlusion at 12-Month Follow-Up After Flow-Diverter Treatment: Statistical Modeling for V&V With Real-World Data
por: Narata, Ana Paula, et al.
Publicado: (2021)

12B. Integrative Medicine in the Treatment of Patients with Asthma
por: Horwitz, Randy
Publicado: (2013)

Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
por: Dobaño, Carlota, et al.
Publicado: (2021)

09A. Preconception Counseling: A Critical Window for the Health Promotion of Children
por: Maizes, Victoria
Publicado: (2013)

Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
por: Alten, Rieke, et al.
Publicado: (2017)

Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe
por: Baraliakos, Xenofon, et al.
Publicado: (2020)

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
por: Kayser, Moritz Z, et al.
Publicado: (2021)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

Changes in Cigarette Smoking and Vaping in Response to the COVID-19 Pandemic in the UK: Findings from Baseline and 12-Month Follow up of HEBECO Study
por: Kale, Dimitra, et al.
Publicado: (2022)

Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
por: Haraoui, Boulos, et al.
Publicado: (2018)

Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting
por: Kato, Motoyasu, et al.
Publicado: (2021)

Efficacy of temperature-guided cryoballoon ablation without using real-time recordings – 12-Month follow-up()
por: Prochnau, Dirk, et al.
Publicado: (2018)

Real world Google SketchUp 7
por: Tadros, Mike
Publicado: (2010)

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
por: Dewilde, Sarah, et al.
Publicado: (2023)

Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA
por: Harrold, Leslie R., et al.
Publicado: (2021)

Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
por: Tichá, Veronika, et al.
Publicado: (2016)

ID: 218293 Real World Outcome Data in Pandemic: A Tertiary Care Neuromodulation Centre UK- 12 Months Data
por: Ahmad, Alia, et al.
Publicado: (2023)

Real‐world outcomes in cardiac resynchronization therapy patients: design and baseline demographics of the SMART‐ Registry
por: Gardner, Roy S., et al.
Publicado: (2021)

Outcome after major trauma: 12-month follow-up
por: Anthi, A, et al.
Publicado: (2000)

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study
por: Alten, Rieke, et al.
Publicado: (2017)

Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a ‘real-world’ view
por: McFarlane, Michael, et al.
Publicado: (2016)

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
por: Raman, Lavanya, et al.
Publicado: (2023)

Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study
por: Rakic, Jean-Marie, et al.
Publicado: (2013)

Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
por: Hurwitz, Jason T., et al.
Publicado: (2020)

Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)
por: Hurwitz, Jason T., et al.
Publicado: (2022)

Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients
por: Hurwitz, Jason T, et al.
Publicado: (2021)

Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
por: Seijas-Amigo, Jose, et al.
Publicado: (2023)

Assessment of real-world usage of lanreotide AUTOGEL 120 in Polish acromegalic patients – results from the prospective 12-month phase of Lanro-Study
por: Orlewska, Ewa, et al.
Publicado: (2013)

Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
por: Sehgal, Shekhar, et al.
Publicado: (2015)

Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result
por: Lip, P L, et al.
Publicado: (2018)

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
por: Armstrong, April W., et al.
Publicado: (2022)

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months
por: Moll-Udina, Aina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jgqgoc4ld32slcqgdgo35ri807